StonvexLoading…
StonvexStonvexStonvexCore line items from AMPG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $25.20M | $9.51M | $15.58M |
Operating Income | $-7.32M | $-8.43M | $-2.58M |
Net Income | $-7.01M | $-11.24M | $-2.47M |
EPS (Diluted) | $-0.33 | $-1.04 | $-0.26 |
Total Assets | $51.48M | $43.22M | $31.41M |
Total Liabilities | $18.62M | $5.73M | $4.73M |
Cash & Equivalents | $4.98M | $19.32M | $6.73M |
Free Cash Flow OCF − CapEx | $-9.70M | $-5.34M | $-4.44M |
Shares Outstanding | 20.68M | 19.66M | 9.71M |